Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.81
-0.30 (-2.29%)
At close: Mar 24, 2026, 4:00 PM EDT
13.17
+0.36 (2.81%)
After-hours: Mar 24, 2026, 7:53 PM EDT
Intellia Therapeutics Analyst Ratings
Total Analysts
20
Consensus Rating
Buy
Price Target
$20.45
Upside
+59.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Hold → Strong Buy Upgrades $29 | Hold → Strong Buy | Upgrades | $29 | +126.39% | Mar 4, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $54 → $48 | Strong Buy | Maintains | $54 → $48 | +274.71% | Mar 3, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +126.39% | Mar 3, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $9 → $15 | Hold | Maintains | $9 → $15 | +17.10% | Mar 3, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $12 → $15 | Hold | Maintains | $12 → $15 | +17.10% | Mar 3, 2026 |
| Citizens | Citizens | Buy Maintains $21 → $28 | Buy | Maintains | $21 → $28 | +118.58% | Mar 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +134.19% | Mar 3, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $26 → $27 | Strong Buy | Maintains | $26 → $27 | +110.77% | Mar 2, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $26 | Strong Buy | Maintains | $26 | +102.97% | Feb 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $25 | Strong Buy | Maintains | $15 → $25 | +95.16% | Jan 28, 2026 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 11, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $17 → $8 | Buy → Hold | Downgrades | $17 → $8 | -37.55% | Nov 11, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $25 → $14 | Strong Buy | Reiterates | $25 → $14 | +9.29% | Nov 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +17.10% | Nov 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $48 → $26 | Strong Buy | Maintains | $48 → $26 | +102.97% | Nov 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.